Inovio shares are going back to $5, Citron Research says

Andrew Left’s Citron Research said via Twitter, “$INO back to $5. Consider this as JNJ enters Phase 3: MRNA – 30,000 patients; BNTX/PFE – 40,000 patients; JNJ – 60,000 patients; AZN – 30,000 patients; Inovio- 40 patients…not 40k….40. AND 15 guinea pigs.” Shares of Inovio Pharmaceuticals are down 8% to $15.57 in morning trading.